A collection of features and news articles published in ASH Clinical News related to bleeding disorders.
U.K. Denying Benefit to Patients With Sickle Cell Disease
The U.K. government has been withholding personal independence payments (PIPs) from patients with sickle cell disease because the condition does not fit government criteria...
Voxelotor Increases Hemoglobin, Decreases Hemolysis in Patients With Sickle Cell Disease
A report from the phase III HOPE trial found that once-daily voxelotor led to greater increases in hemoglobin (Hb) levels and larger reductions in...
Bluebird Bio Wins European Approval for Beta Thalassemia Gene Therapy
Bluebird Bio’s one-time gene therapy, Zynteglo, has been cleared by E.U. regulators for the treatment of beta thalassemia in patients aged 12 and older....
Erythropoietin Increases Hemoglobin and Reticulocyte Counts in Patients with Treatment-Refractory AIHA
In patients with autoimmune hemolytic anemia (AIHA) unresponsive to ongoing and/or prior therapies, treatment with erythropoietin (EPO) effectively increased hemoglobin (Hb) and reticulocyte counts,...
Evaluating Rozanolixizumab in Primary Immune Thrombocytopenia
Rozanolixizumab, at doses ranging from 4 to 15 mg/kg, induced platelet responses in patients with primary immune thrombocytopenia (ITP), according to an interim analysis...
FDA Approves First Anticoagulant for Pediatric Patients
The FDA approved dalteparin sodium, administered as a subcutaneous injection, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients (≥1 month).
Dalteparin...
Study Finds Urgent Need for Sickle Cell Disease Screening Among African Refugees in Italy
Most refugees who arrive at the Mediterranean coast of Italy and other southern European countries are leaving areas where sickle cell disease (SCD) is...
FDA Expands Avatrombopag’s Indication for Chronic Immune Thrombocytopenia
The U.S. Food and Drug Administration (FDA) granted approval to a supplemental new drug application for avatrombopag, expanding its use to include the treatment...
How does triple X syndrome interact with Fanconi anemia?
This month, Joanne Kurtzberg, MD, discusses allogeneic hematopoietic cell transplantation in a patient with Fanconi anemia.
And don't forget to check out next month's clinical...
India Sees Decline in Cases of Severe Anemia
India is home to one-quarter of patients with severe anemia, but a new report from the country’s Health Management Information System found that incidence...
